Delivery Order SPE2DR25D3505-SPE2DR26F96S8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,932.38 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on January 9, 2026, with completion scheduled for January 12, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,822.46 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,018.04 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,359.25 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 19, 2025, with completion scheduled for December 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a direct supply transaction to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $81,684.20 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on September 24, 2025, with an ultimate completion date of September 25, 2025. This is a firm fixed price, non-set-aside delivery order executed under a competitive procurement process. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $8,731.21 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on October 24, 2025, with completion expected by October 27, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement typical of pharmaceutical supply transactions under the DLA's medical procurement framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Vemlidy 25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract has a ceiling value of $7,019.30 and was executed on December 22, 2025, with an ultimate completion date of December 23, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken facility, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $5,823.97 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets in a quantity of 30 units. The contract, awarded on November 7, 2025, with an ultimate completion date of November 10, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a $7,299.76 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 16, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,057.57 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) with a completion date of December 2, 2025. This firm fixed-price contract, awarded December 1, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen's Conshohocken, Pennsylvania facility will serve as the place of performance for this delivery order. This delivery...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F96S8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,042.32 to AmerisourceBergen Drug Corp for supply of Vemlidy 25 mg tablets (30 count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., operates as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables the contractor to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contractor's extensive experience fulfilling federal pharmaceutical requirements and consistent competitively-awarded contract history demonstrate its capability to meet government medical supply demands.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/8/26 |